Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/20/2026 | Q4 | $6.7B | -- | -- | $1.95 | -- |
| 10/28/2025 | Q3 | $9.4B | $9.7B | $3.04 | $3.27 | -$0.23 |
| 07/22/2025 | Q2 | $8.8B | $9.2B | $3.36 | $2.90 | $0.46 |
| 04/17/2025 | Q1 | $8B | $7.7B | $2.58 | $2.70 | -$0.12 |
| 01/21/2025 | Q4 | $7.1B | $7.6B | $2.61 | $2.36 | $0.26 |
| 10/29/2024 | Q3 | $10.2B | $10B | $3.92 | $4.17 | -$0.25 |
| 07/18/2024 | Q2 | $9.6B | $10B | $4.10 | $3.78 | $0.32 |
| 04/18/2024 | Q1 | $8.2B | $9.1B | $3.52 | $3.07 | $0.45 |
| 01/23/2024 | Q4 | $7.6B | $7.7B | $2.82 | $2.88 | -$0.05 |
| 11/07/2023 | Q3 | -- | $10.5B | $4.45 | -- | -- |
| 07/20/2023 | Q2 | -- | $9.7B | $3.90 | -- | -- |
| 04/20/2023 | Q1 | -- | $8B | $2.73 | -- | -- |
| 01/24/2023 | Q4 | -- | $7.3B | $2.76 | -- | -- |
| 11/09/2022 | Q3 | -- | $9.6B | $4.67 | -- | -- |
| 07/21/2022 | Q2 | -- | $8.8B | $4.67 | -- | -- |
| 04/26/2022 | Q1 | -- | $8B | $4.03 | -- | -- |
| 02/02/2022 | Q4 | -- | $7.1B | $3.17 | -- | -- |
| 11/09/2021 | Q3 | -- | $8.1B | $3.70 | -- | -- |
| 07/22/2021 | Q2 | -- | $7.3B | $3.06 | -- | -- |
| 04/22/2021 | Q1 | -- | $6.4B | $2.53 | -- | -- |
| 01/26/2021 | Q4 | -- | $5.9B | $2.14 | -- | -- |
| 11/10/2020 | Q3 | -- | $6.4B | $2.24 | -- | -- |
| 07/28/2020 | Q2 | -- | $5.4B | $1.72 | -- | -- |
| 04/28/2020 | Q1 | -- | $4.5B | $1.30 | -- | -- |
| 01/27/2020 | Q4 | -- | $4B | $1.16 | -- | -- |
| 11/12/2019 | Q3 | -- | $5B | $1.35 | -- | -- |
| 07/30/2019 | Q2 | -- | $4.9B | $1.26 | -- | -- |
| 04/25/2019 | Q1 | -- | $4.1B | $0.93 | -- | -- |
| 01/25/2019 | Q4 | -- | $3.5B | $0.76 | -- | -- |
| 11/08/2018 | Q3 | -- | $4.5B | $1.22 | -- | -- |
| 07/26/2018 | Q2 | -- | $4.4B | $1.18 | -- | -- |
| 04/26/2018 | Q1 | -- | $3.8B | $0.91 | -- | -- |
| 01/31/2018 | Q4 | -- | $3.3B | $0.49 | -- | -- |
| 11/09/2017 | Q3 | -- | $4.2B | $0.82 | -- | -- |
| 07/26/2017 | Q2 | -- | $3.8B | $0.76 | -- | -- |
| 04/20/2017 | Q1 | -- | $3.3B | $0.60 | -- | -- |
| 01/24/2017 | Q4 | -- | $2.9B | $0.55 | -- | -- |
| 11/08/2016 | Q3 | -- | $3.7B | $0.75 | -- | -- |
| 07/21/2016 | Q2 | -- | $3.2B | $0.66 | -- | -- |
| 04/21/2016 | Q1 | -- | $2.8B | $0.52 | -- | -- |
| 01/25/2016 | Q4 | -- | $2.4B | $0.42 | -- | -- |
D.R. Horton, Inc. reported $9.7B worth of top line sales in its most recent quarter.
D.R. Horton, Inc. announced earnings per share of $3.04 which represents a miss of analyst forecast a $3.27 per share.
D.R. Horton, Inc. reported $2.1B that represents $7.05 per share over the last quarter.
D.R. Horton, Inc.'s earnings are forecast to decrease from $11.57 per share to $11.81 per share next year representing a decrease of -1.56%.
D.R. Horton, Inc.'s next earnings date is January 20, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.